These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21725499)

  • 21. [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].
    Xu L; Liu LX; Chen WF; Xie JX; Huang WX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):1-5. PubMed ID: 21141541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
    Morgan WW; Nelson JF
    Brain Res; 2001 Dec; 921(1-2):115-21. PubMed ID: 11720717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
    Alam G; Edler M; Burchfield S; Richardson JR
    Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of GABA transaminase immunoreactivity in the rat substantia nigra pars reticulata.
    Yung KK; Tse YC; Gao ZG; Choi SY; Kwok FS
    Neurosci Lett; 1998 Aug; 253(1):57-60. PubMed ID: 9754804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.
    Grant RJ; Clarke PB
    Neuroscience; 2002; 115(4):1281-94. PubMed ID: 12453497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters.
    Vriend J; Dreger L
    Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons.
    Aumann TD; Egan K; Lim J; Boon WC; Bye CR; Chua HK; Baban N; Parish CL; Bobrovskaya L; Dickson P; Horne MK
    J Neurochem; 2011 Feb; 116(4):646-58. PubMed ID: 21166807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
    Aumann TD
    J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?
    Luquin N; Mitrofanis J
    Parkinsonism Relat Disord; 2008; 14(3):213-23. PubMed ID: 18029221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of melatonin on the nigrostriatal dopamine system in the zitter rat.
    Hashimoto K; Ueda S; Ehara A; Sakakibara S; Yoshimoto K; Hirata K
    Neurosci Lett; 2012 Jan; 506(1):79-83. PubMed ID: 22056485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra.
    Soriano MA; Justicia C; Ferrer I; Rodríguez-Farré E; Planas AM
    Neurobiol Dis; 1997; 4(5):376-85. PubMed ID: 9440126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
    Janson AM; Fuxe K
    Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study.
    Di Matteo V; Benigno A; Pierucci M; Giuliano DA; Crescimanno G; Esposito E; Di Giovanni G
    Ann N Y Acad Sci; 2006 Nov; 1089():462-71. PubMed ID: 17261789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.
    Tatton WG; Greenwood CE
    J Neurosci Res; 1991 Dec; 30(4):666-72. PubMed ID: 1686284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The substantia nigra pars compacta of the Göttingen minipig: an anatomical and stereological study.
    Nielsen MS; Sørensen JC; Bjarkam CR
    Brain Struct Funct; 2009 Sep; 213(4-5):481-8. PubMed ID: 19705154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
    Sarabi A; Hoffer BJ; Olson L; Morales M
    J Comp Neurol; 2001 Dec; 441(2):106-17. PubMed ID: 11745638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.
    Sarkar S; Gough B; Raymick J; Beaudoin MA; Ali SF; Virmani A; Binienda ZK
    Neurosci Lett; 2015 Oct; 606():53-9. PubMed ID: 26321151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.